Aristeia Capital »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Aristeia Capital

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Aristeia Capital from 13F filings

Historical chart of Aristeia Capital investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Aristeia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Aristeia Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.4M 5.0M 1.08
2024-03-31 $2.8M 3.0M 0.94

More positions owned by Aristeia Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Liberty Broadband Corp Com Ser C (LBRDK)
Affirm Hldgs Note 11/1 (Principal)
Ishares Bitcoin Tr SHS (IBIT)
Carnival Ads (CUK)
Guardant Health Note 11/1 (Principal)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Liberty Media Corp Del Com Lbty Srm S C (LSXMK)
Block Note 5/0 (Principal)
Wix Note 8/1 (Principal)
Liberty Broadband Corp Com Ser A (LBRDA)
Heico Corp Cl A (HEI.A)
Firstenergy Corp Note 4.000% 5/0 (Principal)
Atlanta Braves Hldgs Com Ser C (BATRK)
Ppl Cap Fdg Note 2.875% 3/1 (Principal)

View all positions for Aristeia Capital

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Deerfield Management Company
Aequim Alternative Investments
Lazard Asset Management
BlackRock
Davidson Kempner Capital Management
Calamos Advisors
Invesco
BlackRock
State Street Corporation
Morgan Stanley
MacKay Shields
Shenkman Capital Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1